Next Generation Therapeutics and Technological Approaches for Treatment of Neurodevelopmental and Rare Diseases in Children
Participation in the conference is free of charge but it is necessary the registration
The BLAVATNIK CENTER for Drug Discovery and the Sagol School of Neuroscience are delighted to invite you to a dedicated conference day.
This unique conference focuses on new therapeutic and technological approaches for treating neurodevelopmental disorders and rare diseases that appear in early child development. Autism spectrum disorder (ASD), neuromuscular diseases, cerebral palsy and other rare diseases affect more than 10 percent of all children.
Recent advances in genomics and specifically pharmacogenomics are shedding light on the mechanisms of these disorders and paving the way to developing new approaches for therapy based on precision medicine. These discoveries might provide answers to more patients and families.In this exciting one-day symposium, leading experts from Israel and abroad will gather to share the latest research and brainstorm to find new solutions and strategic partnerships.
This event is targeted to researchers, clinicians, physicians and healthcare care providers. The event is jontly hosted by the BLAVATNIK CENTER for Drug Discovery and the Sagol School of Neuroscience, Tel Aviv University.
* The event will take place at the Porter School of Environmental Studies Building, at TAU's Campus.